18 March 2022
BigOmics Analytics, a spin-off of the Institute of Oncology Research and Dalle Molle Institute for Artificial Intelligence, announces raising additional funding from Eppendorf, a leading life science company that develops and sells instruments, consumables and services for liquid, sample and cell handling in laboratories worldwide. The additional funding brings the total amount raised so far to CHF 2.7M. It will be used to further develop BigOmics’ platforms, to expand its team and to grow its presence in the market.